Sarepta Therapeutics Balance Sheet - Annual (NASDAQ:SRPT)

Add to My Stocks
$42.54 $1.41 (3.21%) SRPT stock closing price Jul 25, 2017 (Closing)

The financial analysis of a company like Sarepta Therapeutics involves checking the three financial statements of the company in detail, of which the balance sheet is one. Financial strength can be guaged by performing Sarepta Therapeutics stock analysis and by analyzing the balance sheet. Quarterly results announcements include the release of all three financial statements, of which the balance sheet is one. The Sarepta Therapeutics balance sheet for 2016 shows total assets of $424.1M. Sarepta Therapeutics revenue was $5.42M and Sarepta Therapeutics operating cash flow was $-245.82M for the same year. View latest and last 10 year balance sheet data to check Sarepta Therapeutics financial performance..

show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec. 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
Marketable Securities206.12M122.88M136.79M7.25M---0.17M0.28M0.27M
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets26.89M17.38M35.03M3.06M1.53M1.64M1.02M0.77M0.59M0.76M
Sarepta Therapeutics Total Current Assets
Property Plant & Equipment68.14M61.93M58.39M32.37M20.1M20.03M17.03M16.49M18.1M18.64M
Accumulated Depreciation30.34M24.59M19.89M17.32M16.7M15.76M14.96M14.02M12.91M11.81M
Sarepta Therapeutics Net Property Plant & Equipment
Investment & Advances0.78M0.78M0.78M0.64M------
Other Non-Current Assets------1.96M2.37M--
Deferred Charges---------3.06M
Deposits & Other Assets3.96M4.47M2.06M0.02M2.77M0.15M0.12M0.12M0.03M0.03M
Sarepta Therapeutics Total Assets
Notes Payable-2.49M2.49M-------
Accounts Payable29.69M20.23M12.4M17.63M7.53M9.39M1.31M1.38M2.01M3.02M
Current Portion Long-Term Debt10.1M5.93M0.09M0.09M0.08M0.08M0.08M0.07M0.07M0.07M
Current Portion Capital Leases----------
Accrued Expenses31.01M29.05M17.36M5.04M2.74M2.24M2.01M0.92M1.3M1.17M
Income Taxes Payable----------
Other Current Liabilities4.6M4.57M4.5M13.19M68.52M8.87M42.45M31.12M3.89M5.48M
Sarepta Therapeutics Total Current Liabilities
Deferred Taxes/Income5.94M6.17M6.77M6.83M------
Convertible Debt----------
Long-Term Debt6.04M14.96M3.73M1.57M1.66M1.75M1.84M1.92M2M2.07M
Non-Current Capital Leases----------
Other Long-Term Liabilities----0.76M0.99M1.09M0.96M0.51M0.43M
Sarepta Therapeutics Total Liabilities
Minority Interest----------
Preferred Stock----------
Common Stock Net0.01M0.01M---0.01M0.01M0.01M0.01M0.01M
Capital Surplus1.5B1.09B926.76M790.42M554.92M340.96M304.81M299.08M266.03M252.73M
Retained Earnings-1.17B-899.05M-679.02M-543.23M-431.25M-309.96M-307.64M-275.46M-250.31M-226.35M
Treasury Stock----------
Other Liabilities-0.12M-0.11M-0.09M-------
Sarepta Therapeutics Shareholders Equity
Sarepta Therapeutics Total Liabilities & Shareholders Equity
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years
Get Balance sheet for another ticker

Apart from balance sheet items, an investor would do well to keep track of the Sarepta Therapeutics stock price by looking at Sarepta Therapeutics historical stock prices. One can compare PE with industry average by looking at the Sarepta Therapeutics PE ratio chart. The common balance sheet items are:
  • Assets: SRPT total assets, which was at $424.1M for 2016 is a balance sheet item representing value of what Sarepta Therapeutics owns. Assets are brought to aid a firms operations, or to increase its economic value. It must be noted that tech stocks may not have a lot of assets, as the value for these companies is often derived from future earning potential.
  • Liabilities: The total liabilities of Sarepta Therapeutics for 2016 total to $87.41M. Liabilities for a company like Sarepta Therapeutics include bank loans, services which have been availed for which a settlement in the form of cash/ asset transfer needs to be done in future etc. A firm takes on such obligations to grow its business which in turn will generate future economic benefits for its business.

Sarepta Therapeutics Balance Sheet - Key Ratios

Current ratio
Debt to Equity ratio
Asset Turnover

Annual Balance Sheets For Sarepta Therapeutics Inc Peers

Aviragen Therapeutics balance sheet, BioCryst Pharma balance sheet, DBV Tech balance sheet, Gilead Sciences balance sheet, Kythera Biopharma balance sheet